BEUDAMED
    FDA Adverse Event Death Summary report: N

    EUFLEXXA

    MDR report key: 6621394 · Received June 6, 2017

    Report

    Report Number
    MW5070224
    Event Type
    Death
    Date Received
    June 6, 2017
    Report Date
    June 5, 2017
    Manufacturer
    FERRING PHARMACEUTICALS
    Product Code
    MOZ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    PHARMACIST

    Narratives

    Description of Event or Problem · 1

    PATIENT'S WIFE REPORTED PATIENT IS DECEASED. THE DATE OF DEATH WAS NOT PROVIDED. DOSE OR AMOUNT: 10MG/ML. FREQUENCY: WEEKLY FOR 3 WEEKS. ROUTE: UNDER THE SKIN. DATES OF USE: (B)(6) 2015 - ONGOING. DIAGNOSIS OR REASON FOR USE: OSTEOARTHRITIS. IS THE PRODUCT COMPOUNDED: NO. IS THE PRODUCT OVER-THE-COUNTER: NO. EVENT ABATED AFTER USE STOPPED OR DOSE REDUCED: DOESN'T APPLY. EVENT REAPPEARED AFTER REINTRODUCTION: DOESN'T APPLY.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    397875 EUFLEXXA ACID, HYALURONIC INTRAARTICULAR MOZ FERRING PHARMACEUTICALS M14132A

    Patients

    Seq Age Sex Outcome Treatment
    1 66 YR Death